MedTrace Logo

Study on the Compensatory Mechanism of Iodine Nutrition and the Optimal Intake Level of Lactating Women

NCT04492657 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2020-08-11

No results posted yet for this study

Summary

Due to the lack of direct evidence of optimal iodine intake of Chinese children, pregnant and lactating women and infants were found during the recent revision of Chinese dietary reference intakes (DRIs) of iodine in 2013 by the applicant Pro. Zhang, and no systematical research about compensatory mechanism of iodine nutrition in lactating women was found yet. Previous study funded by United Nations International Children's Emergency Fund (UNICEF) cooperated with the international experts on iodine and key project of national natural science foundation of China under the guidance of Pro. Zhang, had obtained the safe intake range of iodine from children and pregnant women, more than 10 joint papers were published, which laid the foundation of population study and international cooperation.

Conditions

  • Nutritional Requirements

Interventions

OTHER

no intervention

Natural exposure of iodine.

Sponsors & Collaborators

  • Tianjin Medical University

    lead OTHER

Principal Investigators

  • JianQiang Lai · Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention

  • XueSong Wang · Shandong Institute of Endemic Disease Control and Prevention

  • YiFan Duan · Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention

  • GuiJun Tan · Tianjin Medical University

  • Wen Chen · Tianjin Medical University

  • YanTing Chen · Tianjin Medical University

  • Min Gao · Tianjin Medical University

  • ZiYun Pan · Tianjin Medical University

  • Michael B Zimmermann, doctorate · Swiss federal institute of Technology (ETH)

  • Elizabeth N Pearce, doctorate · Boston University School of Medicine; Iodine Global Network (IGN)

  • Maria Andersson, doctorate · Swiss federal institute of Technology (ETH); Iodine Global Network (IGN)

Eligibility

Min Age
1 Day
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-12-31
Completion
2024-12-31

Countries

  • United States
  • China
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04492657 on ClinicalTrials.gov